Wright Medical Group, Inc has entered into an exclusive agreement with LifeCell Corporation for the development and supply of a product based on LifeCell’s proprietary tissue matrix technology for orthopaedic applications.
Under the terms of the agreement, the tissue matrix product will be used in conjunction with Wright Medical’s comprehensive bio- orthopaedic portfolio of products.
“The addition of LifeCell’s proprietary acellular tissue matrix product to our current product line of bio-orthopaedic products gives the orthopedic surgeon a means to enhance the patient’s natural regenerative capabilities and speed their recovery. This is another example of Wright’s ability to bring solutions to the challenges that face today’s orthopedic surgeon,” said F. Barry Bays, Wright Medical’s President and CEO.
LifeCell‘s proprietary tissue matrix technology platform removes cells from the tissue and preserves the tissue matrix without damaging the essential biochemical and structural components necessary for normal tissue regeneration.
Wright Medical Group, Inc. is a global orthopaedic medical device company specializing in the design, manufacture and marketing of reconstructive joint devices and bio-orthopaedic materials.
The Company has been in business for more than fifty years and markets its products in over 40 countries worldwide.